Find your next paid study

~$10 – $1,125

Actual pay is set by the research site.

LivaNovaNCT03887715

Emotional RegulationAlcohol Drinking in CollegeEmotional Eating+1 more

REACT: A Just-in-Time Adaptive Intervention to Reduce Reactive Digital Behavior in College Students

This study looks at the moments when college students feel a strong emotional swing, and how those moments relate to reacting online when upset, drinking alcoh…

University of FloridaNCT07789314

Actual pay is set by the research site.

Phase 3

A Randomized, Open-Label, Multicenter, Phase 3 Study of Zilovertamab Vedotin (MK-2140) in Combination With R-CHP Versus R-CHOP in Participants With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) (waveLINE-010)

The purpose of this study is to evaluate if zilovertamab vedotin with standard treatment can help people live longer without the cancer growing or spreading th…

Diffuse Large B-Cell Lymphoma

Merck Sharp & Dohme LLCNCT06717347

~$50 – $2,100

Actual pay is set by the research site.

Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening

Developing a Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening Among Rural Screening Age-Eligible Adults

This study will garner preliminary data to develop a young adult-mediated intervention whereby a younger family member encourages their older family member to …

Virginia Commonwealth UniversityNCT05936931

Actual pay is set by the research site.

Colon PolypAdenomaSerrated Polyp+2 more

Six Versus Twelve Month SurveillAnce Following Resection of Nonpedunculated ColorectaL Polyps 20-50 mm IN Size Without High Grade Dysplasia (HGD)

The study will compare the use of a 6-month follow-up vs a 12-month follow-up after the removal of a large non-pedunculated polyp 20-50mm in size and without h…

Indiana UniversityNCT07198945

Actual pay is set by the research site.

Phase 2

A Phase 2, Randomized, Open-label Study of VVD-133214 in COmbination With Pembrolizumab Compared to Pembrolizumab Monotherapy in Participants With Advanced Colorectal Adenocarcinoma (CRC) Harboring Microsatellite Instability (MSI) and/or Deficient Mismatch Repair (DMMR)

Researchers are looking for a better way to treat people with advanced colorectal cancer. Colorectal cancer (cancer of the colon or rectum) is one of the most…

Colorectal Adenocarcinoma

Vividion Therapeutics, Inc.NCT07811193

~$75 – $2,800

Actual pay is set by the research site.

Phase 1

A Phase 1/2, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of TNG456 Monotherapy and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

This is a first in human study of TNG456 alone and in combination with abemaciclib in patients with advanced or metastatic solid tumors known to have an MTAP l…

Non Small Cell Lung CancerGlioma Glioblastoma MultiformeGlioma, Malignant+4 more

Tango Therapeutics, Inc.NCT06810544

~$150 – $4,200

Actual pay is set by the research site.

Whole Genome SequencingAcute Myeloid LeukemiaMyelodysplastic Syndromes

A Prospective Study of Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS

This is a single institution, prospective study of the whole genome sequencing assay, ChromoSeq. Using prospectively collected patient data, coupled with physi…

Washington University School of MedicineNCT04986657

Actual pay is set by the research site.

Phase 3

A Multicenter, Open-label, Phase 3 Extension Study to Evaluate the Long-term Efficacy and Safety in Participants Who Are Currently on Treatment in a Belzutifan Study (LITESPARK-043)

Researchers are looking for new ways to treat advanced solid tumors and von Hippel-Lindau (VHL)-related tumors: * Advanced means the cancer has spread to othe…

Von Hippel-Lindau DiseaseMalignant Neoplasms

Merck Sharp & Dohme LLCNCT07405164

~$50 – $2,100

Actual pay is set by the research site.

Tobacco UseTobacco Use Cessation

Automating Tobacco Cessation in Primary Care Via EHR Integration: A Non-Randomized Trial

This study focuses on improving how primary care teams identify patients who smoke and offer access to nicotine replacement therapy, or NRT. NRT includes medic…

University of PennsylvaniaNCT07735286

Actual pay is set by the research site.

Phase 3

A Phase 3, Double-Blind, Randomized, Two-Period, Multicenter, Placebo-Controlled, Efficacy and Safety Study of JNT-517 for the Treatment of Participants With Phenylketonuria

This Phase 3 study will evaluate the safety, effectiveness, tolerability, and how the body processes JNT-517 in children, adolescents, and adults with phenylke…

Phenylketonuria

Otsuka Pharmaceutical Development & Commercialization, Inc.NCT06971731

~$50 – $2,100

Actual pay is set by the research site.

Phase 2

A Phase 2 Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants With Methamphetamine Use Disorder Not Seeking Treatment Receiving a Single Dose of Methamphetamine

The purpose of the study is to evaluate the safety, efficacy, and pharmacokinetics of four single, increasing doses of CS-1103, given by intravenous (IV) infus…

Methamphetamine IntoxicationMethamphetamine DisordersMethamphetamine Abuse